Erratum: Corrigendum to “Conazole fungicides inhibit Leydig cell testosterone secretion and androgen receptor activation in vitro” (Toxicology Reports (2014) 1 (271–283) (S2214750014000262) (10.1016/j.toxrep.2014.05.006));Conazole fungicides inhibit Leydig cell testosterone secretion and androgen receptor activation in vitro

Toxicology Reports

Volumn 1, Issue , 2014, Pages 271-283

  Roelofs, Maarke J E ^a,b   Temming, A Roberto ^a   Piersma, Aldert H ^a,b   van den Berg, Martin ^a   van Duursen, Majorie B M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Androgen receptor (AR); Conazole fungicides; Cyproconazole (PubChem CID: 86132); Endocrine disrupting chemicals (EDCs); Fluconazole (PubChem CID: 3365); Flusilazole (PubChem CID: 73675); Hexaconazole (PubChem CID: 66461); MA 10 Leydig cells; Myclobutanil (PubChem CID: 6336); Penconazole (PubChem CID: 91693); Prochloraz (PubChem CID: 73665); Spermatogenesis; Tebuconazole (PubChem CID: 86102); Testosterone (T); Triadimefon (PubChem CID: 39385); Triticonazole (PubChem CID: 6537961)

Indexed keywords

7 CHLORO 2 (3 PYRIDYL) ALPHA TETRALONE; ANDROGEN RECEPTOR; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYPROCONAZOLE; FLUCONAZOLE; FLUSILAZOLE; FLUTAMIDE; FUNGICIDE; HEXACONAZOLE; MYCLOBUTANIL; MYCONAZOLE; PROCHLORAZ; REACTIVE OXYGEN METABOLITE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TEBUCONAZOLE; TRIADIMEFON; TRITICONAZOLE; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CHOLESTEROL SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENCY; EC50; GENE EXPRESSION; HORMONE ACTION; HUMAN; HUMAN CELL; LEYDIG CELL; LUMINESCENCE; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; TESTOSTERONE RELEASE;

EID: 84921441576     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2016.09.002     Document Type: Erratum

References (50)

1. Andersson A.M., Jorgensen N., Main K.M., Toppari J., Rajpert-De Meyts E., Leffers H., et al. Adverse trends in male reproductive health: we may have reached a crucial 'tipping point'. Int. J. Androl. 2008, 31:74-80.
2. Jorgensen N., Joensen U.N., Jensen T.K., Jensen M.B., Almstrup K., Olesen I.A., et al. Human semen quality in the new millennium: a prospective cross-sectional population-based study of 4867 men. BMJ Open 2012, 2. (Print 2012). 10.1136/bmjopen-2012-000990.
3. Travison T.G., Araujo A.B., O'Donnell A.B., Kupelian V., McKinlay J.B. A population-level decline in serum testosterone levels in American men. J. Clin. Endocrinol. Metab. 2007, 92:196-202.
4. Nyboe Andersen A., Erb K. Register data on Assisted Reproductive Technology (ART) in Europe including a detailed description of ART in Denmark. Int. J. Androl. 2006, 29:12-16.
5. Sharlip I.D., Jarow J.P., Belker A.M., Lipshultz L.I., Sigman M., Thomas A.J., et al. Best practice policies for male infertility. Fertil. Steril. 2002, 77:873-882.
6. Jurewicz J., Hanke W., Radwan M., Bonde J.P. Environmental factors and semen quality. Int. J. Occup. Med. Environ. Health 2009, 22:305-329.
7. Wong E.W., Cheng C.Y. Impacts of environmental toxicants on male reproductive dysfunction. Trends Pharmacol. Sci. 2011, 32:290-299.
8. Roeleveld N., Bretveld R. The impact of pesticides on male fertility. Curr. Opin. Obstet. Gynecol. 2008, 20:229-233.
9. Zarn J.A., Bruschweiler B.J., Schlatter J.R. Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase. Environ. Health Perspect. 2003, 111:255-261.
10. Kjaerstad M.B., Taxvig C., Nellemann C., Vinggaard A.M., Andersen H.R. Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals. Reprod. Toxicol. 2010, 30:573-582.
11. Strushkevich N., Usanov S.A., Park H.W. Structural basis of human CYP51 inhibition by antifungal azoles. J. Mol. Biol. 2010, 397:1067-1078.
12. Hermsen S.A., Pronk T.E., van den Brandhof E.J., van der Ven L.T., Piersma A.H. Triazole-induced gene expression changes in the zebrafish embryo. Reprod. Toxicol. 2012, 34:216-224.
13. Taxvig C., Vinggaard A.M., Hass U., Axelstad M., Metzdorff S., Nellemann C. Endocrine-disrupting properties in vivo of widely used azole fungicides. Int. J. Androl. 2008, 31:170-177.
14. Page S.T. Physiologic role and regulation of intratesticular sex steroids. Curr. Opin. Endocrinol. Diabetes Obes. 2011, 18:217-223.
15. Ge R.S., Dong Q., Sottas C.M., Papadopoulos V., Zirkin B.R., Hardy M.P. In search of rat stem Leydig cells: identification, isolation, and lineage-specific development. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2719-2724.
16. Wang R.S., Yeh S., Tzeng C.R., Chang C. Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice. Endocr. Rev. 2009, 30:119-132.
17. Odum J., Ashby J. Detection of aromatase inhibitors in vitro using rat ovary microsomes. Toxicol. Lett. 2002, 129:119-122.
18. Sanderson J.T., Boerma J., Lansbergen G.W., van den Berg M. Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells. Toxicol. Appl. Pharmacol. 2002, 182:44-54.
19. Vinggaard A.M., Hnida C., Breinholt V., Larsen J.C. Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro. Toxicol. In Vitro 2000, 14:227-234.
20. Roelofs M.J., Piersma A.H., van den Berg M., van Duursen M.B. The relevance of chemical interactions with CYP17 enzyme activity: assessment using a novel in vitro assay. Toxicol. Appl. Pharmacol. 2013, 268:309-317.
21. Laier P., Metzdorff S.B., Borch J., Hagen M.L., Hass U., Christiansen S., et al. Mechanisms of action underlying the antiandrogenic effects of the fungicide prochloraz. Toxicol. Appl. Pharmacol. 2006, 213:160-171.
22. Kahle M., Buerge I.J., Hauser A., Muller M.D., Poiger T. Azole fungicides: occurrence and fate in wastewater and surface waters. Environ. Sci. Technol. 2008, 42:7193-7200.
23. Tebuconazole risk assessment reports, US Environmental Protection Agency. (accessed 22.04.14). http://www.epa.gov/.
24. Pesticides Usages Statistics, Department for Environment, Food & Rural Affairs, UK. (accessed 12.11.13). https://secure.fera.defra.gov.uk/pusstats/.
25. Lavranos G., Balla M., Tzortzopoulou A., Syriou V., Angelopoulou R. Investigating ROS sources in male infertility: a common end for numerous pathways. Reprod. Toxicol. 2012, 34:298-307.
26. Ascoli M. Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses. Endocrinology 1981, 108:88-95.
27. Dankers A.C., Roelofs M.J., Piersma A.H., Sweep F.C., Russel F.G., van den Berg M., et al. Endocrine disruptors differentially target ATP-binding cassette transporters in the blood-testis barrier and affect Leydig cell testosterone secretion in vitro. Toxicol. Sci. 2013.
28. LaCagnin L.B., Levitt M., Bergstrom J.M., Colby H.D. Inhibition of adrenocortical, mitochondrial and microsomal monooxygenases by SU-10'603, a steroid 17 alpha-hydroxylase inhibitor. J. Steroid Biochem. 1989, 33:599-604.
29. Ahn K.C., Zhao B., Chen J., Cherednichenko G., Sanmarti E., Denison M.S., et al. In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens. Environ. Health Perspect. 2008, 116:1203-1210.
30. Simard J., Luthy I., Guay J., Belanger A., Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol. Cell. Endocrinol. 1986, 44:261-270.
31. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 1986, 89:271-277.
32. Scott H.M., Mason J.I., Sharpe R.M. Steroidogenesis in the fetal testis and its susceptibility to disruption by exogenous compounds. Endocr. Rev. 2009, 30:883-925.
33. Makker K., Agarwal A., Sharma R. Oxidative stress & male infertility. Indian J. Med. Res. 2009, 129:357-367.
34. Budefeld T., Jezek D., Rozman D., Majdic G. Initiation of steroidogenesis precedes expression of cholesterologenic enzymes in the fetal mouse testes. Anat. Histol. Embryol. 2009, 38:461-466.
35. Debeljak N., Fink M., Rozman D. Many facets of mammalian lanosterol 14alpha-demethylase from the evolutionarily conserved cytochrome P450 family CYP51. Arch. Biochem. Biophys. 2003, 409:159-171.
36. Ervine C.M., Matthew D.E., Brennan B., Houston J.B. Comparison of ketoconazole and fluconazole as cytochrome P450 inhibitors. Use of steady-state infusion approach to achieve plasma concentration-response relationships. Drug Metab. Dispos. 1996, 24:211-215.
37. Zhang W., Ramamoorthy Y., Kilicarslan T., Nolte H., Tyndale R.F., Sellers E.M. Inhibition of cytochromes P450 by antifungal imidazole derivatives. Drug Metab. Dispos. 2002, 30:314-318.
38. Dreisig K., Taxvig C., Birkhoj Kjaerstad M., Nellemann C., Hass U., Vinggaard A.M. Predictive value of cell assays for developmental toxicity and embryotoxicity of conazole fungicides. ALTEX 2013, 30:319-330.
39. Sanderson J.T. The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. Toxicol. Sci. 2006, 94:3-21.
40. Payne A.H., Youngblood G.L., Sha L., Burgos-Trinidad M., Hammond S.H. Hormonal regulation of steroidogenic enzyme gene expression in Leydig cells. J. Steroid Biochem. Mol. Biol. 1992, 43:895-906.
41. Savchuk I., Soder O., Svechnikov K. Mouse Leydig cells with different androgen production potential are resistant to estrogenic stimuli but responsive to bisphenol a which attenuates testosterone metabolism. PLOS ONE 2013, 8:e71722.
42. Kalla N.R., Nisula B.C., Menard R., Loriaux D.L. The effect of estradiol on testicular testosterone biosynthesis. Endocrinology 1980, 106:35-39.
43. Johnson K.J., Heger N.E., Boekelheide K. Of mice and men (and rats): phthalate-induced fetal testis endocrine disruption is species-dependent. Toxicol. Sci. 2012, 129:235-248.
44. DeVore N.M., Scott E.E. Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001. Nature 2012, 482:116-119.
45. Kami M., Sawada Y., Mori S., Hirate J., Kojima N., Kanda Y., et al. Serum levels of fluconazole in patients after cytotoxic chemotherapy for hematological malignancy. Am. J. Hematol. 2001, 66:85-91.
46. Brammer K.W., Farrow P.R., Faulkner J.K. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev. Infect. Dis. 1990, 12(Suppl. 3):S318-S326.
47. Kortenkamp A. Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology. Int. J. Androl. 2008, 31:233-240.
48. 2+ in an additive manner in dopaminergic PC12 cells. Toxicol. Sci. 2013, 134:374-381.
49. Kjaerstad M.B., Taxvig C., Andersen H.R., Nellemann C. Mixture effects of endocrine disrupting compounds in vitro. Int. J. Androl. 2010, 33:425-433.
50. Kjeldsen L.S., Ghisari M., Bonefeld-Jorgensen E.C. Currently used pesticides and their mixtures affect the function of sex hormone receptors and aromatase enzyme activity. Toxicol. Appl. Pharmacol. 2013, 272:453-464.